Figure 1.

Use of oncolytic viral transfer into cancer cells. The figure is a schematic representation of viral transfer to target rapidly dividing cancer cells. The gene of interest is integrated in the viral genome (left). The engineered virus is administrated and infects rapidly dividing cells, like cancer cells (center). Infected cells then have integrated DNA of the gene of interest that was carried by the virus, resulting in their expression (right).